Neovasc Inc. T.NVC

Primary Symbol: NVCN

Healthcare Medical Instruments & Supplies

Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. The company earns revenue from one source, the Reducer.

NDAQ:NVCN - Post by User

Neovasc Inc. > Leerink downgraded from $5 to $2 on March 28th

<< Previous

Bullboard Posts

Next >>

Comment by pleazu69on Apr 19, 2018 5:17am

100 Views

Post# 27909169

RE:RE:RE:Leerink downgraded from $5 to $2 on March 28th

sorry my spelling has never been good... but rating = buy rating but Im sure everyone picked up on that
remember these targets are all USD

pleazu69 wrote: looks like we gained another analyst. now we have 3 with but ratings on NVCN

this was last report

this is todays report

and this is a pretty graph of the analyst consensus over the last 2 years

pleazu69 wrote: $2 wow that would make allot of dreams come true
even if they downgraded to $1 thats over 1500% profit from todays prices
and that target was before the warrant money hit the bank :)

rimbus wrote: https://thefly.com/landingPageNews.php?id=2706122&headline=NVCN-Neovasc-price-target-lowered-to--from--at-Leerink

Neovasc price target lowered to $2 from $5 at Leerink Leerink analyst Danielle Antalffy lowered her price target for Neovasc to $2 from $5 to reflect significant dilution. The analyst believes the solvency risk is largely mitigated following Q4 sales of $1.2M and as Tiara clinical trials continue to progress. Antalffy reiterates an Outperform rating on the shares.